Prediction of area under the curve for a p-glycoprotein, a CYP3A4 and a CYP2C9 substrate using a single time point strategy: assessment using fexofenadine, itraconazole and losartan and metabolites-Reference-Cited by-同舟云学术

Prediction of area under the curve for a p-glycoprotein, a CYP3A4 and a CYP2C9 substrate using a single time point strategy: assessment using fexofenadine, itraconazole and losartan and metabolites

Published:2015-10-15 Issue:6 Volume:42 Page:945-957
ISSN:0363-9045
Container-title:Drug Development and Industrial Pharmacy
language:en
Short-container-title:Drug Development and Industrial Pharmacy

Author:

Srinivas Nuggehally R.¹

Affiliation:

1. Suramus Bio, Bangalore, Karnataka, India

Publisher

Informa UK Limited

Subject

Organic Chemistry,Drug Discovery,Pharmaceutical Science,Pharmacology

Link

https://www.tandfonline.com/doi/pdf/10.3109/03639045.2015.1096278

Reference96 articles.

1. Therapeutic drug monitoring to adjust dosing in morbid obesity - a new use for an old methodology

2. Potential Drug−Drug Interactions in Infant, Child, and Adolescent Patients in Children’s Hospitals

3. The impact of drug interactions and polypharmacy on antimicrobial therapy in the elderly

4. Antidiabetic Medications and Polypharmacy

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Critical Assessment of Phenotyping Cocktails for Clinical Use in an African Context;Journal of Personalized Medicine;2023-07-05

2. Limitations of fexofenadine limited sampling strategy using plasma concentrations and partial area under the concentration-time curve to estimate transporter activity in healthy adults;Int. Journal of Clinical Pharmacology and Therapeutics;2023-06-01

3. Effect of Chronic Hepatitis C on the Activity of the Membrane Transporters P‐gp and OATP1B1/BCRP on Patients With Different Stages of Hepatic Fibrosis;Clinical Pharmacology & Therapeutics;2023-05-16

4. Fexofenadine Plasma Concentrations to Estimate Systemic Exposure in Healthy Adults Using a Limited Sampling Strategy with a Population Pharmacokinetic Approach;Therapeutic Drug Monitoring;2023-01-13

5. Utility of endogenous 4β-hydroxycholesterol as a biomarker to assess cytochrome P 450 3A (CYP3A) activity: not quite ready for prime time;European Journal of Clinical Pharmacology;2022-09-13